Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

557
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
557
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

248
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
248
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

2.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeting metabolism to protect fertility and healthy pregnancy with SGLT2 inhibitors and GLP-1RAs.

Current opinion in physiology·2026
Same author

Pregnancy hormones reversibly dampen single cell vascular smooth muscle traction force and f-actin alignment.

Journal of biomechanics·2026
Same author

Rat-bite fever diagnosed by polymerase chain reaction of a bite-site crust specimen three weeks after exposure: a case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026
Same author

The influence of lactation on postpartum murine heart growth.

Journal of molecular and cellular cardiology·2025
Same author

Dibothriocephalus nihonkaiensis infection accompanied with vitamin B<sub>12</sub> deficiency: A case report.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2025
Same author

A case of leptospirosis contracted through occupational exposure in the Tokyo metropolitan area.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2025

Related Experiment Video

Updated: Dec 14, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K

Computational models of cardiac hypertrophy.

Kyoko Yoshida1, Jeffrey W Holmes2

  • 1Department of Biomedical Engineering, University of Virginia, Box 800759, Health System, Charlottesville, VA, 22908, USA.

Progress in Biophysics and Molecular Biology
|July 24, 2020
PubMed
Summary

Computational models predict cardiac hypertrophy, or heart growth, but current models cannot predict regression or include hormonal effects. Future models may offer patient-specific predictions by integrating cell-level signaling.

Keywords:
Cardiac biomechanicsComputational modelingGrowthHypertrophy

More Related Videos

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology
08:54

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology

Published on: April 18, 2018

10.0K
Magnetic Adjustment of Afterload in Engineered Heart Tissues
09:40

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

6.2K

Related Experiment Videos

Last Updated: Dec 14, 2025

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
09:20

Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction

Published on: February 13, 2021

6.9K
Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology
08:54

Creating a Structurally Realistic Finite Element Geometric Model of a Cardiomyocyte to Study the Role of Cellular Architecture in Cardiomyocyte Systems Biology

Published on: April 18, 2018

10.0K
Magnetic Adjustment of Afterload in Engineered Heart Tissues
09:40

Magnetic Adjustment of Afterload in Engineered Heart Tissues

Published on: May 5, 2020

6.2K

Area of Science:

  • Cardiovascular Research
  • Biomedical Engineering
  • Computational Biology

Background:

  • Cardiac hypertrophy involves heart mass increase due to hemodynamics, mechanical stimuli, and hormones.
  • It occurs during development, exercise, pregnancy, and in cardiovascular diseases.
  • Computational models show promise for predicting heart growth, especially with mechanical loading.

Purpose of the Study:

  • Review the history and current state of cardiac growth models.
  • Identify limitations of current models for clinical application.
  • Propose a multiscale modeling approach for future cardiac growth prediction.

Main Methods:

  • Literature review of cardiac growth models.
  • Analysis of limitations in predicting growth regression, hemodynamics, and hormonal effects.
  • Exploration of growth mechanics from other biomechanics fields.
  • Proposal of a multiscale modeling approach integrating tissue and cell levels.

Main Results:

  • Current cardiac growth models accurately predict growth under mechanical loading but have limitations.
  • Key limitations include inability to predict growth regression, account for evolving hemodynamics, and incorporate hormonal/drug effects.
  • Lessons from other biomechanics fields can inform cardiac modeling.

Conclusions:

  • Existing computational models offer insights into cardiac hypertrophy but require refinement for clinical use.
  • A multiscale approach combining tissue-level and cell-level signaling models is proposed to address current limitations.
  • Future models aim to provide patient-specific predictions, incorporating hormonal influences, particularly for conditions like pregnancy-induced cardiac changes.